Tag: Healthcare Providers

This webinar for healthcare providers will provide information specific to the Health Canada recently approved biosimilar for denosumab.

Join Dr. Angela Cheung as she speaks to how the denosumab biosimilar compares to the reference drug, what physicians can expect from the clinical results, information on treatment plans, what healthcare providers need to communicate with their patients and more.

In the treatment of osteoporosis, biologic and biosimiar medications may be provided as part of a treatment plan. What do healthcare providers need to know?

Join Dr. Alan Low as he shares information on Biologics & Biosimilars – An Overview for Healthcare Providers. Information presented will include how biologics and biosimilars work, the benefits of biosimilars and how to speak to patients about these new treatment options.

The release of the Osteoporosis Canada 2023 Clinical Practice Guideline will support Canadian healthcare providers in providing the most current evidence-based information for patient centred care to optimise skeletal health and prevent fractures.

Join Dr. Suzanne Morin, lead author and Chair of the 2023 guideline steering committee, as she discusses an overview of the guideline which contain 25 recommendations and 10 good practice statements with a focus on exercise, nutrition, fracture risk assessment, treatment and more – reflecting advances in risk assessment, and non-pharmacologic and pharmacologic management of osteoporosis.